|
|
|
|
Today's Headline
TG2 Identified as Potential Target in Chemo-Resistant Ovarian Cancer -
University of Texas M. D. Anderson Cancer Center have found overexpression of tissue type transglutaminase (TG2) in ovarian cancer is associated with increased tumor cell growth and adhesion, resistance to chemotherapy and lower overall survival rates. When researchers targeted and silenced TG2 in animal models, cancer progression was reversed, suggesting the protein may also provide a novel therapeutic approach for late-stage ovarian cancer. (Read More)
Other News

Featured Sites
Symposia on Cancer Research
OncoLog
Center for Cancer Epigenetics
Genes & Development Ph.D. Program
Research and Clinical Achievements
|